miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice

Figure 7

miR-200a could not provide cardiac protection against DOX-induced acute cardiotoxicity in Nrf2-deficient mice: (a) schedule of Nrf2 deficiency in mice with the acute DOX treatment; (b) the level of Nrf2 in the hearts (); (c) EF (); (d, e) the levels of NT-proBNP and MDA in the hearts (); (f) caspase 3 activity (). .

(a)

(b)

(c)

(d)

(e)

(f)